Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for SARTORIUS (SSSGY : OTC)

• Company Description    Sartorius AG is a pharmaceutical and laboratory equipment supplier. The company manufactures equipment for biomolecular and microbial separations, cell culture, concentration, fermentation and purification. Sartorius AG is headquartered in Goettingen, Germany. Number of Employees: 13,528

• Price / Volume Information    Yesterday's Closing Price: $44.68 Daily Weekly Monthly 20 Day Moving Average: 25 shares Shares Outstanding: 171.19 (millions) Market Capitalization: $7,648.90 (millions) Beta: 0.93 52 Week High: $50.95 52 Week Low: $37.87 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 6.13% 0.94% 12 Week -2.62% -9.97% Year To Date -0.71% -11.75%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL OTTO-BRENNER-STRASSE 20 - GOETTINGEN,2M 37079 DEU ph: 49-55-130-80 fax: 49-55-1308-3289 ben.orzelek@sartorius.com http://www.sartorius.com

• General Corporate Information    Officers Joachim Kreuzburg - Chief Executive Officer and Chairman Florian Funck - Chief Financial Officer Rene Faber - Member of the Executive Board Alexandra Gatzemeyer - Member of the Executive Board Rainer Lehmann - Member of the Executive Board Peer Information SARTORIUS (ABMD) SARTORIUS (DMDS) SARTORIUS (CPWY.) SARTORIUS (EQUR) SARTORIUS (ECIA) SARTORIUS (FMS) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED INSTRUMENTS Sector: Medical CUSIP: 80385Q109 SIC: 3843 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/26 Next Expected EPS Date: 07/28/26 Share - Related Items Shares Outstanding: 171.19 Most Recent Split Date: 1.00 (5.00:1) Beta: 0.93 Market Capitalization: $7,648.90 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.20% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.09 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: 03/30/2026 - $0.09 Next EPS Report Date: 07/28/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: 44.41 PEG Ratio: - Price Ratios Price/Book: - Price/Cash Flow: - Price / Sales: 1.97 EPS Growth vs. Year Ago Period: 9.37% vs. Previous Quarter: -% Sales Growth vs. Year Ago Period: 13.27% vs. Previous Quarter: -% ROE 03/31/26 - - 12/31/25 - - 09/30/25 - 8.19 ROA 03/31/26 - - 12/31/25 - - 09/30/25 - 3.15 Current Ratio 03/31/26 - - 12/31/25 - - 09/30/25 - 0.95 Quick Ratio 03/31/26 - - 12/31/25 - - 09/30/25 - 0.49 Operating Margin 03/31/26 - - 12/31/25 - - 09/30/25 - 8.97 Net Margin 03/31/26 - - 12/31/25 - - 09/30/25 - 3.82 Pre-Tax Margin 03/31/26 - - 12/31/25 - - 09/30/25 - 8.16 Book Value 03/31/26 - - 12/31/25 - - 09/30/25 - - Inventory Turnover 03/31/26 - - 12/31/25 - - 09/30/25 - 2.34 Debt-to-Equity 03/31/26 - - 12/31/25 - - 09/30/25 - 0.89 Debt-to-Capital 03/31/26 - - 12/31/25 - - 09/30/25 - 47.18

Powered by Zacks Investment Research ©